Turkey Pharmaceutical Market report comprehensively covers the market by types, distribution channels and regions. Turkey Pharmaceutical Market report provides an unbiased and detailed analysis of the on-going trends, opportunities/high growth areas, market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
Turkey Pharmaceutical Market Synopsis
Turkey pharmaceutical market has grown significantly in recent years on the back of robust development in healthcare related to the reconstruction and development of hospitals in the country. For instance, European bank investment of approximately $650 million for reconstruction and development of city hospitals. The increase in pharma R&D spending in recent years has aided the growth of the pharma ecosystem, with pharmaceutical manufacturing units increasing to 39 in 2021 from 30 in 2018 and incentives granted to pharmaceutical R&D centres increasing to $119.3 million in 2020 from $88.3 million in 2019. During the covid-19 period, the market was severely impacted by raw material shortages and logistics issues, rising costs, and fluctuating sales. However, the Turkish government's announcement of $15.5 billion stimulus package to protect businesses to mitigate the impact of Covid-19 aided the pharmaceutical industry's growth.
According to the publisher, Turkey Pharmaceutical Market size is projected to grow at a CAGR of 4.2% during 2022-2028. Turkey Pharmaceutical market is likely to experience a growth in the forecast period on account of ongoing construction of remaining phase of "DREAM" project which involves the construction of 14 hospitals would add the bed capacity of 18,794 over the next few years would robust the demand of pharmaceutical medicines in the country. Additionally, medical tourism is one of the growing and one of the major revenue sources of Turkish economy. The revenues earned from medical tourism amounted to $1 billion in the year 2021 and $322 million in the first quarter of 2022, which have seen the rise of 68% from previous year. The initiatives provided by government such as economic medical tours from US and VAT exemptions from health services for non-resident foreigners would burgeon the growth of medical tourism revenues to $5 billion in short term and $10 billion in medium term in the country would bolster the growth in pharmaceutical industry over the coming years.
Market by Types
Pharmaceutical drugs holds the largest market share on the back of an increase in the use of originator and generic medicines. In 2020, the originator and generic medicines witnessed the growth of 21.3% and 10% respectively. Further investment in the manufacturing of medicines related to HIV and Hepatitis by Gilead life sciences with an investment of $60 million is expected to drive growth in the segment in the future.
Market by Regions
Western region dominated the turkey human pharmaceutical market in 2021 on account of increase in the construction of hospitals under "DREAM" project by government including one of the world’s largest hospital in Ankara and the existing manufacturing and export hub located in the provinces of Istanbul, Tekirdag, Bursa, Izmir and Manisa region along with involved rise in expenditure in manufacturing and R&D would be one of the major drivers for growth in this region.
Key Attractiveness of the Report
- COVID-19 Impact on the Market.
- 11 Years Market Numbers.
- Historical Data Starting from 2018 to 2028.
- Base Year: 2022
- Forecast Data until 2028.
- Key Performance Indicators Impacting the Market.
- Major Upcoming Developments and Projects.
Key Highlights of the Report
- Turkey Pharmaceutical Market Overview
- Turkey Pharmaceutical Market Outlook
- Turkey Pharmaceutical Market Forecast
- Historical Data and Forecast of Turkey Pharmaceutical Market Revenues for the Period 2018-2028F
- Historical Data and Forecast of Turkey Pharmaceutical Market Revenues, By Types, for the Period 2018-2028F
- Historical Data and Forecast of Turkey Pharmaceutical Market Revenues, By End Users, for the Period 2018-2028F
- Historical Data and Forecast of Turkey Pharmaceutical Market Revenues, By Regions, for the Period 2018-2028F
- Market Drivers and Restraints
- Industry Life Cycle
- Porter’s Five Force Analysis
- Impact Analysis of COVID-19
- Turkey Pharmaceutical Market Trends
- Turkey Pharmaceutical Market Revenue Share, By Companies
- Competitive Benchmarking
- Company Profiles
- Key Strategic Recommendations
Market Scope and Segmentation
The report provides a detailed analysis of the following market segments:
By Types
- Pharmaceutical Drugs
- Biological Drugs
By Distribution Channels
- Hospital
- Pharmacy and Drug Stores
- E-commerce
- Others
By Regions
- Eastern
- Central
- Western
Table of Contents
1. Executive Summary
2. Introduction
2.1 Report Description
2.2 Key Highlights of the Report
2.3 Market Scope and Segmentation
2.4 Research Methodology
2.5 Assumptions
3. Turkey Pharmaceutical Market Overview
3.1 Turkey Pharmaceutical Market Revenues (2018-2028F)
3.2 Turkey Pharmaceutical Market - Total Addressable Market & Total Production (2021 and 2022E)
3.3 Turkey Pharmaceutical Market - Industry Life Cycle
3.4 Turkey Pharmaceutical Market - SWOT Analysis
4. Impact Analysis of COVID-19 on Turkey Pharmaceutical Market
5. Turkey Pharmaceutical Market Dynamics
5.1 Impact Analysis
5.2 Market Drivers
5.3 Market Restraints
6. Turkey Pharmaceutical Market Trends
7. Turkey Human Pharmaceutical Market Overview, By Types
7.1 Turkey Human Pharmaceutical Market Revenue Share, By Types (2021 & 2028F)
7.1.1 Turkey Human Pharmaceutical Market Revenues, By Types (2018-2028F)
8. Turkey Human Pharmaceutical Market Overview, By Distribution Channels
8.1 Turkey Human Pharmaceutical Market Revenue Share, By Distribution Channels (2021 & 2028F)
8.1.1 Turkey Human Pharmaceutical Market Revenues, By Distribution Channels (2018-2028F)
9. Turkey Human Pharmaceutical Market Overview, By Regions
9.1 Turkey Human Pharmaceutical Market Revenue Share, By Regions (2021 & 2028F)
9.1.1 Turkey Human Pharmaceutical Market Revenues, By Regions (2018-2028F)
10. Turkey Veterinary Pharmaceutical Market Overview, By Types
10.1 Turkey Veterinary Pharmaceutical Market Revenue Share, By Types (2021 & 2028F)
10.1.1 Turkey Veterinary Pharmaceutical Market Revenues, By Types (2018-2028F)
11. Turkey Veterinary Pharmaceutical Market Overview, By Distribution Channels
11.1 Turkey Veterinary Pharmaceutical Market Revenue Share, By Distribution Channels (2021 & 2028F)
11.1.1 Turkey Veterinary Pharmaceutical Market Revenues, By Distribution Channels (2018-2028F)
12. Turkey Veterinary Pharmaceutical Market Overview, By Regions
12.1 Turkey Veterinary Pharmaceutical Market Revenue Share, By Regions (2021 & 2028F)
12.1.1 Turkey Veterinary Pharmaceutical Market Revenues, By Regions (2018-2028F)
13. Turkey Pharmaceutical Market- Key Performance Indicators
14. Turkey Human Pharmaceutical Market Opportunity Assessment
14.1 Turkey Human Pharmaceutical Market Opportunity Assessment, By Types (2028F)
14.2 Turkey Human Pharmaceutical Market Opportunity Assessment, By Distribution Channels (2028F)
14.3 Turkey Human Pharmaceutical Market Opportunity Assessment, By Regions (2028F)
15. Turkey Veterinary Pharmaceutical Market Opportunity Assessment
15.1 Turkey Veterinary Pharmaceutical Market Opportunity Assessment, By Types (2028F)
15.2 Turkey Veterinary Pharmaceutical Market Opportunity Assessment, By Distribution Channels (2028F)
15.3 Turkey Veterinary Pharmaceutical Market Opportunity Assessment, By Regions (2028F)
16. Turkey Pharmaceutical Market Export Statistics
17. Turkey Pharmaceutical Market Government Initiatives, Regulation and Taxation
17.1 Turkey Pharmaceutical Market Government Initiatives
17.2 Turkey Pharmaceutical Market Regulation and Taxation
18. Turkey Pharmaceutical Market Manufacturing Analysis
18.1 Turkey Pharmaceutical Manufacturing Analysis - Assumptions
18.2 Turkey Pharmaceutical Manufacturing Analysis - Fixed Expenditure
18.3 Turkey Pharmaceutical Manufacturing Analysis - Working Capital
18.4 Turkey Pharmaceutical Manufacturing Analysis - Production Cost & Break-Even Analysis
18.5 Turkey Pharmaceutical Manufacturing Analysis - Raw Material Suppliers and Product Distributors
19. Turkey Pharmaceutical Market- Competitive Analysis
19.1 Turkey Pharmaceutical Market Revenue Share, By Companies
19.2 Turkey Pharmaceutical Market Competitive Benchmarking, By Technical Parameters
19.3 Turkey Pharmaceutical Market Competitive Benchmarking, By Operating Parameters
20. Company Profiles
20.1 Bayer Turkiye
20.2 Novartis Turkiye
20.3 Sanofi Turkiye
20.4 Pfizer Turkiye
20.5 Abdi Ibrahim
20.6 Roche Group
20.7 Ceva Animal Health A.S.
20.8 Deva Holding A.S.
20.9 Zoetis Turkiye
20.10 MSD Turkiye
21. Key Strategic Recommendations
22. Disclaimer
List Of Figures
1. Turkey Human and Veterinary Pharmaceutical Market Revenues, 2018-2028F ($ Million)
2. Total Addressable Market, 2021 & 2022E (In $ Billion)
3. Total Production Value, 2021 & 2022E (In $ Billion)
4. Median Age of Turkey Population, 2015-2020 (In Years)
5. Turkey Distribution of Elder Population, Region wise (In Percentage)
6. Turkey Distribution of Healthcare Professionals Across Regions, 2015-2020 (In Units)
7. Turkey Annual Urban Inflation Rate, Sep 21-Sep 22 (In Percentage)
8. Turkey Human Pharmaceutical Market Revenue Share, By Types, 2021 & 2028F
9. Turkey Human Pharmaceutical Market Revenue Share, By Distribution Channels, 2021 & 2028F
10. Turkey Human Pharmaceutical Market Revenue Share, By Regions, 2021 & 2028F
11. Turkey Veterinary Pharmaceutical Market Revenue Share, By Types, 2021 & 2028F
12. Turkey Veterinary Pharmaceutical Market Revenue Share, By Distribution Channels, 2021 & 2028F
13. Turkey Veterinary Pharmaceutical Market Revenue Share, By Regions, 2021 & 2028F
14. Turkey Pharma Market Sales Value, 2015-2020 (In Billion Units)
15. Turkey Pharma Import-Manufactured Value , 2015-2020 (In $ billion)
16. Turkey Pharma Import-Manufactured Value, in Million Value 2015-2020 (In Percentage)
17. Treatment Group by Value in Turkey, 2015-2020 (In Percentage)
18. Number of Hospital Beds, 2010-2020 (In Units)
19. Turkey Healthcare Investment, 2015-2020 (In $ Billion)
20. Turkey Distribution of Hospitals, 2020 (In Percentage)
21. Turkey Number of Healthcare Professionals, By Types, Per Ten Thousand People, 2015-2020 (In Numbers)
22. Turkey Human Pharmaceutical Opportunity Assessment, By Types, 2028F
23. Turkey Human Pharmaceutical Opportunity Assessment, By Distribution Channels, 2028F
24. Turkey Human Pharmaceutical Market Opportunity Assessment, By Region, 2028F
25. Turkey Veterinary Pharmaceutical Market Opportunity Assessment, By Types, 2028F
26. Turkey Veterinary Pharmaceutical Market Opportunity Assessment, By Distribution Channels, 2028F
27. Turkey Veterinary Pharmaceutical Market Opportunity Assessment, By Region, 2028F
28. Turkey Human Pharmaceutical Market Revenue Share, By Companies
29. Turkey Veterinary Pharmaceutical Market Revenue Share, By Companies
List Of Tables
1. Turkey Human Pharmaceutical Market Revenues, By Types, 2018-2028F ($ Million)
2. Turkey Human Pharmaceutical Market Revenues, By Distribution Channels, 2018-2028F ($ Million)
3. Turkey Human Pharmaceutical Market Revenues, By Regions, 2018-2028F ($ Million)
4. Turkey Veterinary Pharmaceutical Market Revenues, By Types, 2018-2028F ($ Million)
5. Turkey Veterinary Pharmaceutical Market Revenues, By Types, 2018-2028F ($ Million)
6. Turkey Veterinary Pharmaceutical Market Revenues, By Types, 2018-2028F ($ Million)
7. Major Countries Adopted Turkey Pharmaceutical Products
8. Potential Countries to Export Pharmaceutical Products
9. Incentives Provided By Government For Pharma Projects
10. Pharma Key Raw Material Suppliers in Turkey
11. Distributor and Retailer of Pharma Products
Companies Mentioned
- Bayer Turkiye
- Novartis Turkiye
- Sanofi Turkiye
- Pfizer Turkiye
- Abdi Ibrahim
- Roche Group
- Ceva Animal Health A.S.
- Deva Holding A.S.
- Zoetis Turkiye
- MSD Turkiye
